Israeli firm receives FDA approval to begin clinical trial of chronic corneal edema treatmentThe company describes EndoArt as the world’s first synthetic endothelial layer for the treatment of chronic corneal edema. ENDOART, A synthetic endothelial layer for the treatment of chronic corneal edema.(photo credit: Courtesy)
